Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Remune: Began Phase III trial

The Immune Response Corp. (IMNR), Carlsbad, Calif.
Product: Remune
Business: Infectious diseases

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE